A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.Paul F. Robbins, Steven A. Rosenberg|The Journal of Experimental Medicine|1996Cited by 547
Telomere Length of Transferred Lymphocytes Correlates with In Vivo Persistence and Tumor Regression in Melanoma Patients Receiving Cell Transfer TherapyJuhua Zhou, Paul F. Robbins|The Journal of Immunology|2005Cited by 330
High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell LinesYangbing Zhao, Richard A. Morgan, Paul F. Robbins et al.|The Journal of Immunology|2007Cited by 216
TIL therapy broadens the tumor-reactive CD8<sup>+</sup>T cell compartment in melanoma patientsPia Kvistborg, Ton N. Schumacher, Chengyi J. Shu et al.|OncoImmunology|2012Cited by 176